NovaBridge Biosciences (NBP) Interest & Investment Income (2019 - 2025)
NovaBridge Biosciences (NBP) reported Interest & Investment Income of $5.8 million for Q3 2025, up 10.02% year-over-year from $5.3 million in Q3 2024, and up 58.47% quarter-over-quarter from $3.7 million in Q2 2025.
NovaBridge Biosciences (NBP) Interest & Investment Income (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 7 years of Interest & Investment Income data on file, last reported at $5.8 million in Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $5.8 million, up 10.02% year-over-year; the trailing twelve-month figure through Sep 2025 was $5.8 million (up 10.02% YoY), and the FY2025 annual result was $7.6 million, up 1.67% from the prior year.
- Interest & Investment Income improved to $5.8 million in Q3 2025 per NBP's latest filing, from $3.7 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $7.0 million in Q3 2023 and troughed at $709000.0 in Q1 2024.
- A 5-year average of $3.4 million and a median of $3.3 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2023: Interest & Investment Income tumbled 45.7% in 2021, then jumped 397.9% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $1.5 million in 2021, then tumbled by 37.89% to $905000.0 in 2022, then surged by 672.27% to $7.0 million in 2023, then decreased by 24.32% to $5.3 million in 2024, then grew by 10.02% to $5.8 million in 2025.
- Business Quant data shows NBP's Interest & Investment Income at $5.8 million in Q3 2025, $3.7 million in Q2 2025, and $1.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 3.67 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Sep 30, 2024 | 5.29 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 709,000.00 |
| Sep 30, 2023 | 6.99 Mn |
| Jun 30, 2023 | 4.51 Mn |
| Jun 30, 2022 | 905,000.00 |
| Jun 30, 2021 | 1.46 Mn |
| Sep 30, 2020 | 2.75 Mn |
| Jun 30, 2020 | 2.68 Mn |
| Sep 30, 2019 | 3.26 Mn |